Hepatitis B virus infection

Ganem, 2004, Hepatitis B virus infection natural history and clinical consequences, N Engl J Med, 350, 1118, 10.1056/NEJMra031087

Hsu, 1986, Baseline seroepidemiology of hepatitis B virus infection in children in Taipei, 1984: a study just before mass hepatitis B vaccination program in Taiwan, J Med Virol, 18, 301, 10.1002/jmv.1890180402

Feret, 1987, Epidemiology of hepatitis B virus infection in the rural community of Tip, Senegal, Am J Epidemiol, 125, 140, 10.1093/oxfordjournals.aje.a114497

Tiollais, 1985, The hepatitis B virus, Nature, 37, 489, 10.1038/317489a0

Lau, 1993, Molecular virology and pathogenesis of hepatitis B, Lancet, 342, 1335, 10.1016/0140-6736(93)92249-S

Stevens, 1975, Vertical transmission of hepatitis B antigen in Taiwan, N Engl J Med, 292, 771, 10.1056/NEJM197504102921503

Hsu, 1993, Horizontal transmission of HBV in children, J Pediatr Gastroenterol Nutr, 16, 66, 10.1097/00005176-199301000-00012

Hieber, 1977, Hepatitis and pregnancy, J Pediatr, 91, 545, 10.1016/S0022-3476(77)80499-X

Beasley, 1982, Incidence of hepatitis B virus infection in preschool children in Taiwan, J Infect Dis, 146, 198, 10.1093/infdis/146.2.198

Beasley, 1983, Incidence of hepatitis among students at a university in Taiwan, Am J Epidemiol, 117, 213, 10.1093/oxfordjournals.aje.a113532

Tang, 1998, Hepatitis B surface antigenemia at birth: a long-term follow-up study, J Pediatr, 133, 374, 10.1016/S0022-3476(98)70272-0

Lin, 1987, Transplacental leakage of HbeAg-positive maternal blood as the most likely route in causing intrauterine infection with hepatitis B virus, J Pediatr, 111, 877, 10.1016/S0022-3476(87)80210-X

Hsu, 1992, Cellular immune response to hepatitis B core antigen in maternal infant transmission of hepatitis B virus, Hepatology, 15, 770, 10.1002/hep.1840150505

Shiraki, 1980, Acute hepatitis B in infants born to carrier mothers with the antibody to hepatitis B e antigen, J Pediatr, 97, 768, 10.1016/S0022-3476(80)80261-7

Chen, 2004, Fulminant hepatic failure in children in endemic area of hepatitis B virus infection: 15years after universal hepatitis B vaccination, Hepatology, 39, 58, 10.1002/hep.20006

Chang, 1987, Fulminant hepatitis in children in Taiwan: the important role of hepatitis B virus, J Pediatr, 111, 34, 10.1016/S0022-3476(87)80338-4

Bortolotti, 1990, Long-term outcome of chronic type B hepatitis in patients who acquire hepatitis B virus in infection in childhood, Gastroenterology, 99, 805, 10.1016/0016-5085(90)90972-4

Chang, 1989, Factors affecting clearance of hepatitis B e antigen in hepatitis B surface antigen carrier children, J Pediatr, 115, 385, 10.1016/S0022-3476(89)80836-4

Bortolotti, 1996, Long-term persistence of hepatitis B virus DNA in the serum of children with chronic hepatitis B after hepatitis B e antigen to antibody seroconversion, J Pediatr Gastroenterol Nutr, 22, 270, 10.1097/00005176-199604000-00008

Bortolotti, 1990, Long-term outcome of chronic type B hepatitis in patients who acquire hepatitis B virus infection in childhood, Gastroenterology, 99, 805, 10.1016/0016-5085(90)90972-4

Bortolotti, 2006, Chronic hepatitis B in children after e antigen seroclearance: final report of a 29-year longitudinal study, Hepatology, 43, 556, 10.1002/hep.21077

Chang, 1995, The significance of spontaneous HBeAg seroconversion in childhood: with special emphasis on the clearance of HBeAg before three years of age, Hepatology, 22, 1387

Wen, 2004, The development of hepatocellular carcinoma among 426 prospectively followed children with chronic hepatitis B virus infection, J Pediatr, 144, 397, 10.1016/j.jpeds.2003.11.022

Chang, 1989, Maternal transmission of hepatitis B virus in childhood hepatocellular carcinoma, Cancer, 64, 2377, 10.1002/1097-0142(19891201)64:11<2377::AID-CNCR2820641130>3.0.CO;2-8

Ni, 2004, Clinical relevance of hepatitis B virus genotype in children with chronic hepatitis B and hepatocellular carcinoma, Gastroenterology, 127, 1733, 10.1053/j.gastro.2004.09.048

Hsu, 1988, Efficacy of a mass hepatitis B vaccination program in Taiwan: studies on 3464 infants of hepatitis B surface antigen-carrier mothers, J Am Med Assoc, 260, 2231, 10.1001/jama.260.15.2231

Shepard, 2006, Hepatitis B virus infection: epidemiology and vaccination, Epidemiol Rev, 28, 112, 10.1093/epirev/mxj009

Poovorawan, 2000, Impact of hepatitis B immunization as part of the EPI, Vaccine, 19, 943, 10.1016/S0264-410X(00)00216-4

WHO. Report on the Expanded Program on Immunization (EPI) of the World Health Organisation (WHO) Department of Vaccines and Biologicals. (Post-exposure immunization for hepatitis B). Geneva: WHO; www.who.immunization/.

Chen, 1996, Seroepidemiology of hepatitis B virus infection in children – ten years of mass vaccination in Taiwan, J Am Med Assoc, 276, 906, 10.1001/jama.276.11.906

Ni, 2001, Hepatitis B virus infection in children and adolescents in a hyperendemic area: 15years after mass hepatitis B vaccination, Ann Intern Med, 135, 796, 10.7326/0003-4819-135-9-200111060-00009

Chang, 1997, Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children, N Engl J Med, 336, 1855, 10.1056/NEJM199706263362602

Chang, 2005, Prevention of hepatocellular carcinoma by universal vaccination against hepatitis B virus: the effect and problems, Clin Cancer Res, 11, 7953, 10.1158/1078-0432.CCR-05-1095

Kao, 2001, Universal hepatitis B vaccination and the decreased mortality from fulminant hepatitis in infants in Taiwan, J Pediatr, 139, 349, 10.1067/mpd.2001.116277

Hsu, 2004, Survey of hepatitis B surface variant infection in children 15years after nationwide vaccination program in Taiwan, Gut, 53, 1499, 10.1136/gut.2003.034223

Hsu, 1999, Changes of hepatitis B surface variants in carrier children before and after universal vaccination in Taiwan, Hepatology, 30, 1312, 10.1002/hep.510300511

Liaw, 2005, Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2005 update, Liver Int, 25, 472, 10.1111/j.1478-3231.2005.01134.x

Van Zonneveld, 2003, Lamivudine treatment during pregnancy to prevent perinatal transmission of hepatitis B virus infection, J Viral Hepatitis, 10, 294, 10.1046/j.1365-2893.2003.00440.x

Xu, 2004, Efficacy and safety of lamivudine in late pregnancy for the prevention of mother-child transmission of hepatitis B: a multicentre, randomized, double-blind, placebo-controlled study, Hepatology, 40, 272A

Torre, 1996, Interferon alfa-2a therapy for chronic hepatitis B in children: a meta-analysis, Clin Infect Dis, 23, 131, 10.1093/clinids/23.1.131

Lai, 1987, Placebo-controlled trial of recombinant α2-interferon in Chinese HBsAg-carrier children, Lancet, 17, 877, 10.1016/S0140-6736(87)91371-7

Barbera, 1994, Recombinant interferon-2a hastens the rate of HBeAg clearance in children with chronic hepatitis B, Hepatology, 20, 287, 10.1002/hep.1840200203

Ruiz-Moreno, 1995, Factors predictive of response to interferon therapy in children with chronic hepatitis B, J Hepatol, 22, 540, 10.1016/0168-8278(95)80448-X

Gregorio, 1996, Lymphoblastoid interferon alfa with or without steroid pretreatment in children with chronic hepatitis B: a multicenter controlled trial, Hepatology, 23, 700, 10.1002/hep.510230407

Vajro, 1996, Prolonged and high dose recombinant interferon alpha-2b alone or after prednisone priming accelerates termination of active viral replication in children with chronic hepatitis B infection, Pediatr Infect Dis J, 15, 223, 10.1097/00006454-199603000-00010

Sokal, 1998, Interferon alpha therapy for chronic hepatitis B in children: a multinational randomized controlled trial, Gastroenterology, 114, 988, 10.1016/S0016-5085(98)70318-X

Torre, 1996, Interferon-α therapy for chronic hepatitis B in children: a meta-analysis, Clin Infect Dis, 23, 131, 10.1093/clinids/23.1.131

Bortolotti, 2000, Long term effect of alpha interferon in children with chronic hepatitis B, Gut, 46, 715, 10.1136/gut.46.5.715

Jonas, 2002, Clinical trial of lamivudine in children with chronic hepatitis B, N Engl J Med, 346, 1706, 10.1056/NEJMoa012452

Sokal, 2006, Long-term lamivudine therapy for children with HBeAg-positive chronic hepatitis B, Hepatology, 43, 225, 10.1002/hep.21020

Zoulin, 1998, Drug therapy for chronic hepatitis B: antiviral efficacy and influence of hepatitis B virus polymerase mutations on the outcome of therapy, J Hepatol, 29, 151, 10.1016/S0168-8278(98)80191-8